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adjuvant intent. We compared plans with Foward Planning -IMRT (FP–
IMRT) adjusted to the delineated breast volume with two other plans 
without the breast delineated (one with standard tangential beams 
with wedges and another with FP-IMRT). The ACOSOG Z0011 trial 
showed the non inferiority of the irradiation of axillary levels I and II 
(included in the irradiated volume when using standard tangential 
beam radiotherapy to the breast) when compared with axillary 
dissection of the same levels, in selected patients with breast cancer.  
Materials and Methods: We analyzed data from 40 patients 
undergoing radiotherapy after breast conserving surgery, with a 
negative sentinel node biopsy. The patients were submitted to a CT 
for virtual simulation with 3mm slice. The data from the CT were 
doubled. In one CT, 2 dosimetry plans were done: one with 
conventional RT with tangential beams with wedges (2-3 segments 
were added if necessary to achieve dose homogeneity) and another 
with FP-IMRT. On the other CT data, target volumes were delineated: 
breast CTV and PTV (expansions of 10 mm were made for all 
directions except for the posterior one, which was 7 mm), and a plan 
was calculated using the FP-IMRT technique, adjusted to the PTV. We 
then outlined the axillary levels I and II, for analysis, on one CT data 
and copied it to the other. Mean dose (Dmean) and V95 were 
evaluated for axillary levels I and II. The Conformity Index (CI) of the 
PTV was also analysed. 
Results: Both V95 and Dmean for axillary level I were higher in the 
standard tangential beams with wedges technique and in the FP-IMRT 
technique without the breast volume delineated. When compared 
with these plans, the plan adjusted to the breast PTV achieved an 
inferior V95 value to axillary level I. When evaluating the axillary level 
II, these differences were more pronounced. We found a higher CI 
value in the plan adjusted to the breast target volume. 
Conclusions: We found a higher conformity index to the breast target 
volume using the FP-IMRT technique with the breast target volumes 
delineated, and a lower V95 for the axillary levels evaluated. This 
shows that when conforming the dose to the breast alone the 
unintended irradiation of the axilla is lower. Although a higher V95 
was achieved with the standard tangential breast irradiation with 
wedges, it happens at the expenses of a lower conformity index to the 
breast volume, and this technique has shown a higher rate of skin 
toxicity, which lead to being less used. We conclude that the 
delineation of axillary levels I and II is mandatory when there is the 
need to irradiate them, and the information obtained by the sentinel 
node biopsy is therefore important to the radiotherapy treatment. 
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Purpose/Objective: Treatment of locally-advanced rectal cancer with 
neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal 
excision has led to better results in sphincter-preservation and local 
recurrence rates in the last years. Achievement of a pathologic 
complete response (ypT0N0) after nCRT consistently associates to 
improved disease free and overall survival. However, no clinical or 
genetic predictorsof complete response are currently available which 
allow patient stratification and personalization of therapeutic 
strategies. Among the multiple pathways involved in CRT resistance, 
inflammatory response has been demonstrated to mediate both micro-
environmental resistance to radiation damage. To evaluate the role of 
functional polymorphisms of inflammatory response genes (NF-kB, 
Cox-1, Cox-2,IL-1beta) in pathological response to nCRT in rectal 
cancer. 
Materials and Methods: We included patients with locally advanced 
rectal cancer treated with nCRT (capecitabine, 3D pelvic 
radiotherapy, with TD 50.4 Gy) at asingle center. Genomic DNA was 
obtained from peripheral blood or paraffin-embedded non-tumor 
tissue. The following polymorphisms were analyzed with Taqman-
based qPCR: rs28362491(NF-Kβ), rs1213266 (COX-1), rs5789 (COX-1), 
rs20417 (COX-2), rs5275 (COX-2),rs16944 (IL-1β) and rs1143627 (IL-1β). 
Association between genotypes and rectal cancer outcome was 
analyzed with logistic regression models (SNPstatssoftware). 
Results: 159 patients have been included; Patient characteristics: 
median age 65 years, 104%males, 55% female. 95% of population had 
Karnofsky 90-100%; stages IIA (27%), IIIA(4%), IIIB (25%), IIIC (45%). 
Abdominoperineal resection was practiced in 30% and lower anterior 
resection in 70% of cases.Surgery included complete mesorectal 
excision in 78% of patient population.Adjuvant chemotherapy was 
administered in 88% of them. Complete pathological response (pCR) 
rate was 18% and nonresponse in 20%. With a median follow-up of 44 
months (range: 11-93), only 30 patients have recurred with local 
and/ormetastatic disease. Overall survival was 85,4% and desease free 
survival 81%.Univariate analysis shown statistically significant impact 
of NFkB associated to pCR and OS. Distribution of genotypic and allelic 
frequencies for the seven polymorphisms was similar to those 
observed in European populations.  
Conclusions: Our work is the first that analyze the relation between 
inflammation gene polymorphisms and response to nCRT in rectal 
cancer treatment. We did not find significant association between the 
genetic polymorphisms (s1213266, rs5789, rs20417, rs5275, rs16944, 
rs1143627) and the pathological response, but we observed impact of 
NF-Kb in relation between pathological response and overall survival. 
We also observed statistically significant relationship between 
performance status and treatment response. Patients with 100-90% 
Karnofsky have cPR or quasi complete pathological response to nCRT. 
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Purpose/Objective: To prospectively validate the efficacy of 18F-
fluorodeoxyglucose (18F-FDG)-positron emission tomo-graphy (PET)-CT 
imaging for predicting histopathological response and clinical long-
term outcomes in locally advanced rectal cancer (LARC). 
Materials and Methods: 38 patients with confirmed diagnosis of LARC 
(cT3–4 or cN+) were prospectively studied with 18F-FDG PET/CT 
before and after neoadjuvant therapy (NAT). Total mesorectal 
excision (TME) was programmed 6 weeks after NAT followed by an 
expert histopathological analysis of the surgical specimen. Baseline 
variables and previously identified cutoff values of pre-NAT 
(SUVmaxPRE ≥ 6), post-NAT (SUVmaxPOST < 2), absolute (?SUVmax ≥ 4) 
and percentage reduction (?SUVmax ≥ 65%) of the baseline maximum 
FDG standardized uptake value (SUVmax) criteria were applied to 
differentiate metabolic tumor responders from non-responders. These 
features were correlated with disease-free survival (DFS) and overall 
survival (OS).  
Results: 19 responder patients (TRG 3-4) showed a statistically 
significantly higher 5-year disease-free survival (DFS) and overall 
survival (OS) compared with 19 non-responders (TRG0-2) patients 
(94.4 vs 48.8%, p=0.001; 94.7 vs 63.2%, p= 0.02). At multivariate 
analysis the only presurgical parameters correlated to the likelihood 
of recurrence and survival were ?SUV (≥ 65% vs < 65%) [HR= 5.2 
(p=0.01); HR= 4.4 (p=0.03)] and tumor histologic grade (I or II vs III) 
[HR=6.2 (p=0.001); HR= 4.1 (p=0.03)].  
Conclusions: This prospective study has proven that 18F-FDG PET/CT 
is a valuable imaging tool for assessing rectal cancer TRG and long-
term prognosis, and could potentially serve as an intermediate 
endpoint in treatment optimization research and rectal cancer patient 
care. 
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Purpose/Objective: This prospective study evaluates feasibility, 
toxicity and early clinical outcomes of concurrent image guided 
volumetric modulated arc therapy (IG-RA) and weekly cisplatin in the 
setting of a definitive chemoradiotherapy for locally advanced 
esophageal cancer. 
Materials and Methods: 41 Patients diagnosed with squamous cell 
carcinoma of esophagus deemed unsuitable for surgery were included 
in the study. Patients with performance status (ECOG) more than 1, 
involvement of cervical esophagus or gastroesophageal junction, 
    
